We are live on
!
Find out more
BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
65 hedge funds and large institutions have $190M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
16% more funds holding
Funds holding: 56 → 65 (+9)
10% more capital invested
Capital invested by funds: $173M → $190M (+$16.9M)
Holders
65
Holders Change
+9
Holders Change %
+16.07%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
13
Reduced
7
Closed
6
Calls
$101K
Puts
–
Net Calls
+$101K
Net Calls Change
+$2K
Top Buyers
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$5.11M |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$4.02M |
| 3 |
CF
Cantor Fitzgerald
New York
|
+$2.98M |
| 4 |
SCM
Saba Capital Management
New York
|
+$2.5M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$2.24M |
